These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27246914)

  • 1. Hyaluronidase 1 Deficiency Preserves Endothelial Function and Glycocalyx Integrity in Early Streptozotocin-Induced Diabetes.
    Dogné S; Rath G; Jouret F; Caron N; Dessy C; Flamion B
    Diabetes; 2016 Sep; 65(9):2742-53. PubMed ID: 27246914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases.
    Dogné S; Flamion B; Caron N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1427-1439. PubMed ID: 29880486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HYAL1 deficiency attenuates lipopolysaccharide-triggered renal injury and endothelial glycocalyx breakdown in septic AKI in mice.
    Xing H; Li S; Fu Y; Wan X; Zhou A; Cao F; Sun Q; Hu N; Ma M; Li W; Cao C
    Ren Fail; 2023 Dec; 45(1):2188966. PubMed ID: 37563795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diabetes and hyaluronidase on the retinal endothelial glycocalyx in mice.
    Leskova W; Pickett H; Eshaq RS; Shrestha B; Pattillo CB; Harris NR
    Exp Eye Res; 2019 Feb; 179():125-131. PubMed ID: 30445048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Glycocalyx Hyaluronan: Regulation and Role in Prevention of Diabetic Complications.
    Wang G; Tiemeier GL; van den Berg BM; Rabelink TJ
    Am J Pathol; 2020 Apr; 190(4):781-790. PubMed ID: 32035886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.
    Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N
    Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction.
    Queisser KA; Mellema RA; Middleton EA; Portier I; Manne BK; Denorme F; Beswick EJ; Rondina MT; Campbell RA; Petrey AC
    JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34314391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role and therapeutic targeting of the glomerular endothelial glycocalyx in lupus nephritis.
    Kadoya H; Yu N; Schiessl IM; Riquier-Brison A; Gyarmati G; Desposito D; Kidokoro K; Butler MJ; Jacob CO; Peti-Peterdi J
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32870819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial Glycocalyx Impairment in Disease: Focus on Hyaluronan Shedding.
    Dogné S; Flamion B
    Am J Pathol; 2020 Apr; 190(4):768-780. PubMed ID: 32035885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover.
    Bourguignon V; Flamion B
    FASEB J; 2016 Jun; 30(6):2108-14. PubMed ID: 26887442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
    Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
    Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting hyaluronan of the endothelial glycocalyx for therapeutic intervention.
    Wheeler-Jones CP; Farrar CE; Pitsillides AA
    Curr Opin Investig Drugs; 2010 Sep; 11(9):997-1006. PubMed ID: 20730694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin impairs glycocalyx barrier properties and attenuates shear dependent vasodilation in mice.
    VanTeeffelen JW; Brands J; Jansen C; Spaan JA; Vink H
    Hypertension; 2007 Jul; 50(1):261-7. PubMed ID: 17452501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocytes/Macrophages Upregulate the Hyaluronidase HYAL1 and Adapt Its Subcellular Trafficking to Promote Extracellular Residency upon Differentiation into Osteoclasts.
    Puissant E; Boonen M
    PLoS One; 2016; 11(10):e0165004. PubMed ID: 27755597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis.
    Tan JX; Wang XY; Su XL; Li HY; Shi Y; Wang L; Ren GS
    PLoS One; 2011; 6(7):e22836. PubMed ID: 21829529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier.
    Jeansson M; Haraldsson B
    Am J Physiol Renal Physiol; 2006 Jan; 290(1):F111-6. PubMed ID: 16091582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Plasma Hyaluronan and Hyaluronidase Be Used As Markers of the Endothelial Glycocalyx State in Patients with Kidney Disease?
    Vlahu CA; Krediet RT
    Adv Perit Dial; 2015; 31():3-6. PubMed ID: 26714379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
    Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
    Posey JT; Soloway MS; Ekici S; Sofer M; Civantos F; Duncan RC; Lokeshwar VB
    Cancer Res; 2003 May; 63(10):2638-44. PubMed ID: 12750291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.
    Lokeshwar VB; Rubinowicz D; Schroeder GL; Forgacs E; Minna JD; Block NL; Nadji M; Lokeshwar BL
    J Biol Chem; 2001 Apr; 276(15):11922-32. PubMed ID: 11278412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.